KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2025)

Historic Income from Non-Controlling Interests for Adaptive Biotechnologies (ADPT) over the last 5 years, with Q3 2025 value amounting to -$1000.0.

  • Adaptive Biotechnologies' Income from Non-Controlling Interests rose 9615.38% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year increase of 11634.62%. This contributed to the annual value of -$103000.0 for FY2024, which is 9074.07% down from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Income from Non-Controlling Interests is -$1000.0, which was up 9615.38% from $21000.0 recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Income from Non-Controlling Interests ranged from a high of $76000.0 in Q4 2021 and a low of -$95000.0 during Q3 2021
  • For the 5-year period, Adaptive Biotechnologies' Income from Non-Controlling Interests averaged around -$18294.1, with its median value being -$26000.0 (2023).
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first plummeted by 250000.0% in 2024, then skyrocketed by 18461.54% in 2025.
  • Adaptive Biotechnologies' Income from Non-Controlling Interests (Quarter) stood at $76000.0 in 2021, then plummeted by 153.95% to -$41000.0 in 2022, then surged by 36.59% to -$26000.0 in 2023, then increased by 3.85% to -$25000.0 in 2024, then surged by 96.0% to -$1000.0 in 2025.
  • Its last three reported values are -$1000.0 in Q3 2025, $21000.0 for Q2 2025, and $22000.0 during Q1 2025.